Johns Hopkins-Allegheny Health Network (AHN) Cancer Research Fund Award
Johns Hopkins Department of Radiation Oncology & Molecular Radiation Sciences and One Health Group team jointly win coveted award
In September 2017, the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins announced the fourth annual request for applications for the Johns Hopkins-Allegheny Health Network Cancer Research Fund. Hopkins-AHN awards fund cancer research projects at the level of $100,000 direct costs per year, with an award term of two years. It is expected that these awards seek to answer innovative questions in cancer research and potentially lead to successful, longer-term funding from other funding sources.
Recipients of the Hopkins-AHN awards were notified this past February. An exciting project that was awarded is a joint effort between the Johns Hopkins University Department of Radiation Oncology & Molecular Radiation Sciences and One Health Group (OHG). The collaborative project will commence in early April 2018, with its primary goal being to pioneer non-ionizing, very low power electromagnetic waves as a viable tool for real-time imaging. According to the joint academia-industry team, the specific project aims are:
-
Development of an RF radar system for detection of moving lung tumors;
-
Exploration and development of an RF radar system to detect pancreas or liver fiducial markers; and
-
Verification and refinement of both prototype systems using physical phantoms.
About Johns Hopkins Department of Radiation Oncology and Molecular Radiation Sciences: The Department is dedicated to a three-part mission — clinical expertise, advanced research initiatives, and thorough training of our residents. All of these culminate in patient-centered, specialized care for those who are treated by our team. By constantly improving our radiation therapy technology through our clinical research, we enhance our ability to provide the most advanced treatment options that are specific to every patient’s disease.
About One Health Group: Like its namesake, OHG is a medical technology innovator that is focused on the interrelationship of animal, human, and environmental health, whose mission is to bring breakthrough health diagnostics, therapeutics, monitoring, screening, and advanced analytics to market in an accelerated manner. OHG fully expects to have a radically positive impact on clinical outcomes, while addressing major global pressures to make excellent healthcare more affordable and accessible.
Media Contact: info@ohgcorp.com
